Company
Xsensio
Revolutionizing Patient Monitoring Through Real-Time Biochemical Sensing
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
- Headquarters
- Lausanne, Switzerland
- Customers
- healthcare providers
Claim, correct or request removal
Record updated 18 September 2026
About
At Xsensio, we are pioneering a new era of patient monitoring with our Lab-on-Skin(c) sensing platform. Designed for real-time, continuous tracking of inflammation and other critical biomarkers, our technology enables earlier detection of clinical deterioration — from ICU settings to outpatient care and the home.
Funding snapshot
- Total raised
- $7MSum of rounds, as of 2026-09-18Source (opens in a new tab)
- Latest round
- Series A, $7M2026-03-02
Funding rounds
- Series A
- $7M2026-03-02, Company stated
Products
- Hardware
- Lab-on-Skin
Loading relationship preview